On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

RYAH Group, Inc. (CSE: RYAH) Enters New Zealand Market

  • A partnership with Medical Kiwi LTD makes it possible for RYAH to enter the New Zealand Market
  • Medical Kiwi was the first South Island-based company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate
  • The potential market for medical cannabis in New Zealand is at NZ$1.5 billion

RYAH Group (CSE: RYAH), a health care analytics and technology company, has entered the New Zealand market through a definitive wholesale supply and distribution agreement with Medical Kiwi LTD (https://cnw.fm/gDWk5). This agreement enables RYAH’s suite of IoT devices and cloud-based data analytics to be used in pre-clinical and clinical trial settings and medical patient care alongside Medical Kiwi’s medical cannabis formulations.

“Our new partnership with Medical Kiwi Ltd in New Zealand further expands our global clinical and distribution network for plant-based medicine and digital patient care,” said Gregory Wagner, CEO of RYAH Group Inc. and of RYAH Medtech, Inc.

Medical Kiwi is a leader in research and development, manufacturing, cultivation and distribution of medical cannabis and medical devices in New Zealand. The Company has built a strong health-based, scientific and business savvy team. It offers assurance from seed to sale and has built a reputation on innovation, excellence, quality, transparency and service. It was the first South Island-based Company to be granted a Medicinal Cannabis license from the Ministry of Health to cultivate.

It is difficult for importers of cannabis to enter the New Zealand market, and many who were once there are pulling out, unable to meet stiff new government standards (https://cnw.fm/yD5Ny). Medical Kiwi’s medical cannabis formulations are cultivated, produced, and sold domestically. The analytics that RYAH’s IoT and cloud-based data analytics will help provide the necessary information the country desires in its journey to find safer, more effective medicinal products and better understand the medicinal effects.

RYAH is not the cannabis supplier but instead creates partnerships that enable doctors and patients to personalize plant-based treatments to predict treatment outcomes better. The artificial intelligence platform aggregates and correlates HIPAA-compliant patient data throughout the patient session and formulation lifecycle.

The Ministry of Health estimates that over 250,000 casual cannabis users use it for medicinal purposes, with a potential market estimated at NZ$1.5 billion (https://cnw.fm/9pTU0).

“Our new relationship with Medical Kiwi presents an opportunity for both parties to drive innovation and to deliver cutting edge plant-based medical solutions in New Zealand,” stated Wagner.

In addition to the partnership, RYAH and Medical Kiwi are looking to explore the medical device registration of RYAH’s Smart-Inhaler, the first of its kind in New Zealand.

For more information, visit the company’s website at www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group are available in the company’s newsroom at https://cnw.fm/RYAH

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722